Nika Pharmaceuticals, Inc SEC filings NIKA
Nika Pharmaceuticals, Inc has 71 filings in SEC EDGAR's recent list, going back to Dec 3, 2020. Its latest annual report, Form 10-K, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2024 (auditor change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Auditor change
|
Oct 16, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Auditor change
|
Oct 1, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Acquisition or sale of assets
|
Aug 27, 2024 | Aug 18, 2024 |
| 8-K |
Current report
Acquisition or sale of assets, Other events
|
May 10, 2024 | Apr 23, 2024 |
| 8-K |
Current report
Acquisition or sale of assets
|
Apr 15, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Acquisition or sale of assets, Bylaw or fiscal year change
|
Mar 5, 2024 | Mar 1, 2024 |
| 8-K |
Current report
Auditor change
|
Feb 16, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control
|
Sep 18, 2023 | Sep 18, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 15, 2022 | Nov 12, 2022 |
| 8-K |
Current report
Auditor change
|
Nov 1, 2022 | Oct 31, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 22, 2022 | Aug 22, 2022 |
| 8-K |
Current report
Acquisition or sale of assets, Change to shareholder rights
|
Apr 12, 2022 | Apr 12, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 5, 2022 | Apr 5, 2022 |
Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NIKA (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- CO
- Headquarters
- Henderson, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1145604
- Former names
- CENTENNIAL GROWTH EQUITIES INC (until Aug 15, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.